Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy

Combination therapy which enhances efficacy and reduces toxicity, has been increasingly applied as a promising strategy for cancer therapy. Here, a reactive oxygen species (ROS) that enhanced combination chemotherapy nanodevices was fabricated based on the Fe-chelated polydopamine (PDA) nanoparticle...

Full description

Bibliographic Details
Main Authors: Xu-Jing Li, Wen-Tong Li, Zi-Hao-Ran Li, Li-Ping Zhang, Cheng-Cheng Gai, Wei-Fen Zhang, De-Jun Ding
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00075/full
_version_ 1818162670580269056
author Xu-Jing Li
Wen-Tong Li
Wen-Tong Li
Zi-Hao-Ran Li
Li-Ping Zhang
Cheng-Cheng Gai
Wei-Fen Zhang
Wei-Fen Zhang
De-Jun Ding
De-Jun Ding
author_facet Xu-Jing Li
Wen-Tong Li
Wen-Tong Li
Zi-Hao-Ran Li
Li-Ping Zhang
Cheng-Cheng Gai
Wei-Fen Zhang
Wei-Fen Zhang
De-Jun Ding
De-Jun Ding
author_sort Xu-Jing Li
collection DOAJ
description Combination therapy which enhances efficacy and reduces toxicity, has been increasingly applied as a promising strategy for cancer therapy. Here, a reactive oxygen species (ROS) that enhanced combination chemotherapy nanodevices was fabricated based on the Fe-chelated polydopamine (PDA) nanoparticles (NPs). The structure was characterized by dynamic light scattering-autosizer, transmission electron microscopy, energy dispersive spectroscopy, and Fourier-transform infrared (FT-IR) spectrophotometer. The in vitro drug release profile triggered by low intracellular pH indicated that the system demonstrated controlled therapeutic activity. In vitro cell uptake studies showed that doxorubicin (DOX)-loaded Fe-PDA/ folic acid (FA)- polyethylene glycol (DOX@Fe-PDA/FA-PEG) had a strong uptake capacity and can be rapidly internalized by MCF-7 cells. The in vitro experiments demonstrated that DOX@Fe-PDA/FA-PEG triggered the intracellular ROS overproduction, thereby enhancing its therapeutic effect on breast cancer. In summary, this experiment demonstrated the novel DOX-loaded composite NPs used as a potential targeted nanocarrier for breast cancer treatment, which could be a promising therapeutic strategy against breast cancer.
first_indexed 2024-12-11T16:37:21Z
format Article
id doaj.art-e647151eb62241c08d80625dbd609fe2
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T16:37:21Z
publishDate 2019-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-e647151eb62241c08d80625dbd609fe22022-12-22T00:58:25ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-02-011010.3389/fphar.2019.00075442167Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination TherapyXu-Jing Li0Wen-Tong Li1Wen-Tong Li2Zi-Hao-Ran Li3Li-Ping Zhang4Cheng-Cheng Gai5Wei-Fen Zhang6Wei-Fen Zhang7De-Jun Ding8De-Jun Ding9Department of Pathology, Weifang Medical University, Weifang, ChinaDepartment of Pathology, Weifang Medical University, Weifang, ChinaCollaborative Innovation Center for Target Drug Delivery System, Weifang Medical University, Weifang, ChinaDepartment of Pathology, Weifang Medical University, Weifang, ChinaCollege of Pharmacy, Weifang Medical University, Weifang, ChinaDepartment of Pathology, Weifang Medical University, Weifang, ChinaCollaborative Innovation Center for Target Drug Delivery System, Weifang Medical University, Weifang, ChinaCollege of Pharmacy, Weifang Medical University, Weifang, ChinaCollaborative Innovation Center for Target Drug Delivery System, Weifang Medical University, Weifang, ChinaCollege of Pharmacy, Weifang Medical University, Weifang, ChinaCombination therapy which enhances efficacy and reduces toxicity, has been increasingly applied as a promising strategy for cancer therapy. Here, a reactive oxygen species (ROS) that enhanced combination chemotherapy nanodevices was fabricated based on the Fe-chelated polydopamine (PDA) nanoparticles (NPs). The structure was characterized by dynamic light scattering-autosizer, transmission electron microscopy, energy dispersive spectroscopy, and Fourier-transform infrared (FT-IR) spectrophotometer. The in vitro drug release profile triggered by low intracellular pH indicated that the system demonstrated controlled therapeutic activity. In vitro cell uptake studies showed that doxorubicin (DOX)-loaded Fe-PDA/ folic acid (FA)- polyethylene glycol (DOX@Fe-PDA/FA-PEG) had a strong uptake capacity and can be rapidly internalized by MCF-7 cells. The in vitro experiments demonstrated that DOX@Fe-PDA/FA-PEG triggered the intracellular ROS overproduction, thereby enhancing its therapeutic effect on breast cancer. In summary, this experiment demonstrated the novel DOX-loaded composite NPs used as a potential targeted nanocarrier for breast cancer treatment, which could be a promising therapeutic strategy against breast cancer.https://www.frontiersin.org/article/10.3389/fphar.2019.00075/fullpolydopaminecombination therapyreactive oxygen speciesdoxorubicinbreast cancer
spellingShingle Xu-Jing Li
Wen-Tong Li
Wen-Tong Li
Zi-Hao-Ran Li
Li-Ping Zhang
Cheng-Cheng Gai
Wei-Fen Zhang
Wei-Fen Zhang
De-Jun Ding
De-Jun Ding
Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy
Frontiers in Pharmacology
polydopamine
combination therapy
reactive oxygen species
doxorubicin
breast cancer
title Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy
title_full Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy
title_fullStr Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy
title_full_unstemmed Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy
title_short Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy
title_sort iron chelated polydopamine decorated doxorubicin loaded nanodevices for reactive oxygen species enhanced cancer combination therapy
topic polydopamine
combination therapy
reactive oxygen species
doxorubicin
breast cancer
url https://www.frontiersin.org/article/10.3389/fphar.2019.00075/full
work_keys_str_mv AT xujingli ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT wentongli ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT wentongli ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT zihaoranli ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT lipingzhang ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT chengchenggai ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT weifenzhang ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT weifenzhang ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT dejunding ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy
AT dejunding ironchelatedpolydopaminedecorateddoxorubicinloadednanodevicesforreactiveoxygenspeciesenhancedcancercombinationtherapy